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SUMMARY
5 Summary
Deﬁciency of the intramembrane protease SPPL2a is known to affect B cell development and
function in murine model systems. In contrast, in SPPL2a–deﬁcient patients B cell frequencies
measured in peripheral blood are normal. Instead, they display a reduction of the conventional
DC 2 (cDC2) population, causing mendelian susceptibility to mycobacterial disease (MSMD).
Therefore, it was aimed to further elucidate the role of SPPL2a in DC development and func-
tion, especially in regard to responses towards mycobacterial infections. Furthermore, due
to its critical role for B cell defects in SPPL2a–deﬁcient mice, the relevance of the SPPL2a
substrate CD74 for possible DC alterations was studied. For this purpose, DCs from either
SPPL2a -/- or SPPL2a -/-CD74 -/- mice were analysed in vivo and in vitro by various cell bio-
logical methods. SPPL2a -/- mice displayed a reduction of the cDC2 population, which was
CD74–dependent. In vitro differentiated SPPL2a -/- BMDCs were in general responsive towards
different pattern recognition receptor (PRR) ligands with speciﬁc alterations in signalling and cy-
tokine expression. Surface levels of the PRR Dectin–1 were reduced, while Toll–like receptor
4 (TLR4) surface expression was increased on SPPL2a -/- BMDCs. This may contribute to the
observed reduced IL–10 and IL–2 expression following Dectin–1 activation and enhanced IL-1β
release when TLR4 ligands were applied to SPPL2a -/- BMDCs. These alterations in cytokine
responses were also observed when heat–killed Mycobacterium tuberculosis was used to ac-
tivate SPPL2a -/- BMDCs. These effects were dependent on the CD74 NTF accumulation, as
they were reversed in SPPL2a -/-CD74 -/- BMDCs. Furthermore, upon co–culture with Mycobac-
terium bovis Bacille Calmette-Gue´rin (BCG), the pathogen to which SPPL2a–deﬁcient patients
show an increased susceptibility, SPPL2a -/- BMDCs released reduced amounts of IL–12 family
cytokines, which are important to induce clearance of mycobacteria.
In summary, SPPL2a–deﬁciency affects DC development and function in a CD74–dependent
manner with important consequences on their ability to clear mycobacterial infections. The al-
tered surface abundance of PRR receptors and the disturbed cytokine response observed in
SPPL2a -/- BMDCs possibly contributes to MSMD in SPPL2a–deﬁcient patients. Reductions of
the anti–inﬂammatory cytokine IL–10 together with enhanced IL–1β responses could lead to
enhanced inﬂammatory responses with increased tissue damage, thereby creating an environ-
ment supporting the spreading of mycobacteria. Reduced release of IL–12 family members by
SPPL2a -/- BMDCs could result in impaired induction of T helper cell type 1 responses, which
are required for clearance of mycobacteria. Thus, the results from this thesis reveal that MSMD
in SPPL2a–deﬁcient humans is not not only caused by the reduced frequency of cDC2 popu-
lation, but also by a functional deﬁcit of the remaining DCs.
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